The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Int J Mol Sci. 2022 Dec 18;23(24):16168. doi: 10.3390/ijms232416168.
We report a case of a patient with Dubin-Johnson syndrome confirmed by a genetic study. A 50-year-old woman who had symptoms of intermittent right upper quadrant abdominal pain was diagnosed with calculous cholecystitis at another institute and was presented to our hospital for a cholecystectomy. She had no history of liver disease, and her physical examination was normal. Abdominal computed tomography showed a gallbladder stone with chronic cholecystitis. During a laparoscopic cholecystectomy for cholecystitis, a smooth, black-colored liver was noted, and a liver biopsy was performed. The biopsy specimen showed coarse, dark brown granules in centrilobular hepatocytes via hematoxylin and eosin staining. We performed a genetic study using the blood samples of the patient. In the () mutation study, a missense mutation in exon 18 was noted. Based on the black-colored liver without nodularity, conjugated hyperbilirubinemia, the liver biopsy results of the coarse pigment in centrilobular hepatocytes, and the mutation, Dubin-Johnson syndrome was diagnosed. The patient was managed with conservative care using hepatotonics. One month after follow-up, total bilirubin and direct bilirubin remained in a similar range. Another follow-up was planned a month later, and the patient maintained her use of hepatotonics.
我们报告了一例经基因研究证实的杜宾-约翰逊综合征患者。一名 50 岁女性因间歇性右上腹疼痛就诊,在另一所医院被诊断为胆石性胆囊炎,并被转至我院行胆囊切除术。她无肝病病史,体格检查正常。腹部 CT 显示胆囊结石伴慢性胆囊炎。在腹腔镜胆囊切除术中,注意到肝脏呈光滑的黑色,进行了肝活检。肝活检标本显示苏木精和伊红染色的中央区肝细胞中有粗而深褐色的颗粒。我们使用患者的血液样本进行了基因研究。在 () 突变研究中,注意到外显子 18 中的错义突变。根据无结节性黑色肝脏、结合胆红素升高、中央区肝细胞中粗色素的肝活检结果以及 突变,诊断为杜宾-约翰逊综合征。患者接受了使用肝药的保守治疗。随访 1 个月后,总胆红素和直接胆红素仍处于相似范围。计划在 1 个月后再次随访,患者继续使用肝药。